SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-019073
Filing Date
2020-07-14
Accepted
2020-07-14 16:05:27
Documents
2
Period of Report
2020-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2153
2 EX-24 DOCUMENT attachment1.htm EX-24 3588
  Complete submission text file 0000899243-20-019073.txt   7094
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Garland J. Scott (Reporting) CIK: 0001533228 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36644 | Film No.: 201027233